CENTOGENE Reports Full Year 2023 Financial Results and Recent Business Highlights
GlobeNewswire
· Reported Full Year 2023 total revenues of 2% growth at €48.5 million
· Secured approximately USD 20 million –..
· Reported Full Year 2023 total revenues of 2% growth at €48.5 million
· Secured approximately USD 20 million –..
Neuralink opened the application for its human trials in September. • The company has reportedly received interest from thousands..
Strong Revenues and Steady Growth in Both Diagnostics and Pharma Segments Drive Sustainable Financial Performance
·..